That was a post on the Yahoo! message boards from Aug. 10, 2006. The stock referenced had dropped nearly 50% since the beginning of the year, yet it had more than tripled its revenue year over year and looked to be on the verge of dominating its only competitor.
Bait ... and switch!
Plain and simple, there are no stocks worth betting the house on. If anyone tells you that, run in the opposite direction. That's because even "seemingly enticing situations" can turn out to be not so enticing after all. The stock in question with our Yahoo! poster was Sirius Satellite Radio, and along with those growing revenues, it had massive debt obligations, more than $1 billion in losses over the past year, and a troubling addiction to shareholder dilution.
So what has Sirius done since Aug. 10, 2006? It's dropped 17%. In other words, we're hoping our poster was speaking in hyperbole and isn't currently servicing the debt he took on to buy Sirius shares.
You guys are too much
We're not speaking in hyperbole here. More Americans are playing the market without realizing that they're assuming risks that can decimate their brokerage accounts, their savings accounts, and, yes, even their homes. According to a recent New York Times article by Floyd Norris, "American investors are now deeper in debt — at least in their margin accounts — than ever before."
You can see the disaster lying in wait here. When folks are margined out, they're likely to get hit hard when the market sours — particularly if they own stocks with triple-digit P/E ratios, or worse, triple-digit price-to-sales ratios.
Seriously, it happened
Recently, we happened on a painful post on our Motley Fool message boards written by a gentleman who maxed out his margin account in 2000 to buy shares of Celera as it fell.
Like our Sirius poster, he had the right idea. He wanted to make a big bet on a stock that he thought the market was treating unfairly.
Unfortunately, Celera also shared another trait with Sirius: It was losing more than $100 million each year.
That did not stop investors from buying big into Celera's plans to map the human gene. Optimism for the company was so great that at its peak, shares sold for 263 times sales.
That's right: 263 times sales. For context, even a fast grower such as WebMD (Nasdaq: WBMD) fetches but 8.7 times sales. Genentech (NYSE: DNA), American Express (NYSE: AXP), and Danaher (NYSE: DHR), some of the top holdings of T. Rowe Price Growth Stock (PRGFX), sell for just 6.7, 2.3, and 2.4 times sales, respectively!
We probably don't need to tell you how it ended for our poster or for anyone else who went whole hog on Celera in 2000. The company's stock chart tells the whole story.
You're better than that
While the Celera tale may be extreme, it's certainly not the only anecdote of its kind. That's why we advise you to adhere strictly to an investing philosophy that suits your goals, risk tolerance, and time frame — even if you've happened across a so-called stock to bet the house on. Because big margin bets one year ago on seemingly better-priced stocks such as Citigroup (NYSE: C), Lowe's (NYSE: LOW), and Wal-Mart (NYSE: WMT) also could have gone wrong.
For example, here's what Fool co-founders and Stock Advisor analysts David and Tom Gardner recommend for any investor who is less than an expert:
Supercharge your returns
The easiest way to crush the market over the next few decades is to be the patient, long-term owner of great companies. And if you can do that and be disciplined in your stock picking, you'll never have to bet the house in order to help you buy a house ... or two.
But if you decide margin has a place in your portfolio, we're not here to tell you that you're wrong. Margin can enhance your returns. But if you use too much and don't know what you're doing, it can wipe out your life's savings. That's why we recommend that:
Of course, if you ask us, patient, long-term investors in great companies don't need margin. After all, that's the tack we take at Stock Advisor, where our picks are ahead of the market by more than 35 percentage points on average. You can see all of those picks, as well as our top five for new money, with a no-obligation 30-day free trial. Click here for more information.
This feature may not be reproduced or distributed electronically, in print or otherwise without the written permission of uclick and Universal Press Syndicate.
